143 related articles for article (PubMed ID: 16603698)
1. Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions.
Ye Y; Lin Y; Atar S; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1158-69. PubMed ID: 16603698
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury.
Birnbaum Y; Ye Y; Rosanio S; Tavackoli S; Hu ZY; Schwarz ER; Uretsky BF
Cardiovasc Res; 2005 Feb; 65(2):345-55. PubMed ID: 15639473
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone protects the myocardium against ischemia-reperfusion injury in eNOS and iNOS knockout mice.
Ye Y; Lin Y; Manickavasagam S; Perez-Polo JR; Tieu BC; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2436-46. PubMed ID: 18931027
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.
Atar S; Ye Y; Lin Y; Freeberg SY; Nishi SP; Rosanio S; Huang MH; Uretsky BF; Perez-Polo JR; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1960-8. PubMed ID: 16339820
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin.
Rosanio S; Ye Y; Atar S; Rahman AM; Freeberg SY; Huang MH; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2006 Feb; 20(1):27-36. PubMed ID: 16435070
[TBL] [Abstract][Full Text] [Related]
6. The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin.
Ye Y; Martinez JD; Perez-Polo RJ; Lin Y; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H343-51. PubMed ID: 18469150
[TBL] [Abstract][Full Text] [Related]
7. Additive effect of TAK-491, a new angiotensin receptor blocker, and pioglitazone, in reducing myocardial infarct size.
Ye Y; Keyes KT; Zhang CF; Perez-Polo JR; Lin Y; Birnbaum Y
Cardiovasc Drugs Ther; 2010 Apr; 24(2):107-20. PubMed ID: 20379769
[TBL] [Abstract][Full Text] [Related]
8. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Nishi SP; Martinez JD; Huang MH; Uretsky BF; Perez-Polo JR
Circulation; 2006 Aug; 114(9):929-35. PubMed ID: 16908763
[TBL] [Abstract][Full Text] [Related]
9. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart.
Birnbaum Y; Ye Y; Lin Y; Freeberg SY; Huang MH; Perez-Polo JR; Uretsky BF
Prostaglandins Other Lipid Mediat; 2007 Feb; 83(1-2):89-98. PubMed ID: 17259075
[TBL] [Abstract][Full Text] [Related]
10. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation.
Manickavasagam S; Ye Y; Lin Y; Perez-Polo RJ; Huang MH; Lui CY; Hughes MG; McAdoo DJ; Uretsky BF; Birnbaum Y
Cardiovasc Drugs Ther; 2007 Oct; 21(5):321-30. PubMed ID: 17620005
[TBL] [Abstract][Full Text] [Related]
11. Pioglitazone limits myocardial infarct size, activates Akt, and upregulates cPLA2 and COX-2 in a PPAR-γ-independent manner.
Birnbaum Y; Long B; Qian J; Perez-Polo JR; Ye Y
Basic Res Cardiol; 2011 May; 106(3):431-46. PubMed ID: 21360043
[TBL] [Abstract][Full Text] [Related]
12. Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2.
Ye Y; Nishi SP; Manickavasagam S; Lin Y; Huang MH; Perez-Polo JR; Uretsky BF; Birnbaum Y
Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):43-53. PubMed ID: 17643887
[TBL] [Abstract][Full Text] [Related]
13. Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin.
Birnbaum Y; Lin Y; Ye Y; Martinez JD; Huang MH; Lui CY; Perez-Polo JR; Uretsky BF
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2891-7. PubMed ID: 17277020
[TBL] [Abstract][Full Text] [Related]
14. The myocardial infarct size-limiting effect of sitagliptin is PKA-dependent, whereas the protective effect of pioglitazone is partially dependent on PKA.
Ye Y; Keyes KT; Zhang C; Perez-Polo JR; Lin Y; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1454-65. PubMed ID: 20207816
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination.
Ye Y; Lin Y; Perez-Polo R; Huang MH; Hughes MG; McAdoo DJ; Manickavasagam S; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H813-8. PubMed ID: 17416607
[TBL] [Abstract][Full Text] [Related]
16. Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat.
Ye Y; Abu Said GH; Lin Y; Manickavasagam S; Hughes MG; McAdoo DJ; Perez-Polo RJ; Birnbaum Y
Cardiovasc Drugs Ther; 2008 Aug; 22(4):275-82. PubMed ID: 18327703
[TBL] [Abstract][Full Text] [Related]
17. Pioglitazone attenuates myocardial ischemia-reperfusion injury via up-regulation of ERK and COX-2.
Wang H; Zhu QW; Ye P; Li ZB; Li Y; Cao ZL; Shen L
Biosci Trends; 2012 Dec; 6(6):325-32. PubMed ID: 23337792
[TBL] [Abstract][Full Text] [Related]
18. Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone.
Ye Y; Lin Y; Perez-Polo JR; Birnbaum Y
Cardiovasc Drugs Ther; 2008 Dec; 22(6):429-36. PubMed ID: 18825491
[TBL] [Abstract][Full Text] [Related]
19. The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation.
Merla R; Ye Y; Lin Y; Manickavasagam S; Huang MH; Perez-Polo RJ; Uretsky BF; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2007 Sep; 293(3):H1918-28. PubMed ID: 17616749
[TBL] [Abstract][Full Text] [Related]
20. Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury.
Bi XY; He X; Zhao M; Yu XJ; Zang WJ
J Cardiovasc Pharmacol; 2013 May; 61(5):391-400. PubMed ID: 23364605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
